Argenx.com

  1. Home
  2. Argenx.com

argenx Homepage

WEBReaching Patients ThroughImmunology Innovation. The science of co-creation drives our quest to engineer life-changing immunology solutions, the resilient spirit of patients fuels …

Actived: 3 days ago

URL: https://www.argenx.com/

argenx Reports Topline Results from ADVANCE-SC Study of …

WEBAbout the ADVANCE-SC Study. The ADVANCE-SC trial was a randomized, double-blind, placebo-controlled, multicenter, global trial evaluating the efficacy and safety of …

Category:  Health Go Health

argenx Highlights Strategic Priorities for 2022 Argenx

WEBargenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced its …

Category:  Health Go Health

argenx Highlights 2024 Strategic Priorities Argenx

WEBJanuary 8, 2024. argenx Highlights 2024 Strategic Priorities. Amsterdam, the Netherlands. Reported $1.2 billion in preliminary* full-year 2023 global net product sales. Submitted …

Category:  Health Go Health

Patient Support Program VYVGART (efgartigimod alfa-fcab)

WEBThe committed team of Case Coordinators and Nurse Case Managers at My VYVGART Path offers:. Patient-specific benefit verifications, including confirming out-of-pocket …

Category:  Health Go Health

argenx announces publication of Phase 3 ADAPT trial results …

WEBthe FDA for the treatment of gMG, and if approved, we look forward to bringing this therapy to MG patients who are in great need of new treatment options.”

Category:  Health Go Health

argenx Announces U.S. Food and Drug Administration (FDA) …

WEBargenx Announces U.S. Food and Drug Administration (FDA) Approval of VYVGART (efgartigimod alfa-fcab) in Generalized Myasthenia Gravis VYVGART is the first-and …

Category:  Food Go Health

Healthcare Reform

WEBHealthcare Reform In the U.S., the EU and other foreign jurisdictions, there have been a number of legislative and regulatory changes to the healthcare systems that could affect …

Category:  Health Go Health

argenx to Present at BofA Securities 2024 Health Care Conference

WEBargenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that …

Category:  Health Go Health

argenx Innovation

WEBThe Immunology Innovation Program (IIP) is a core business strategy of argenx connecting the specialized insight into disease and target biology of our external scientific and …

Category:  Health Go Health

Healthcare Law and Regulation

WEBOn May 21, 2021, PhRMA sued the HHS in the U.S. District Court for the District of Columbia, to stop the implementation of the rule claiming that the rule contradicts federal …

Category:  Health Go Health

2022 Environmental, Social and Governance Report

WEB2 2022 E Report Table of Contents Message from our CEO 03 The argenx Purpose 04 Our Philosophy on ESG 06 Patients 07 People 21 Governance 29 Planet 35

Category:  Health Go Health

argenx Announces European Commission Approval of …

WEBargenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today …

Category:  Health Go Health

argenx Announces Positive Phase 3 Data from ADVANCE Trial of …

WEBargenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today …

Category:  Health Go Health

argenx Highlights 2023 Strategic Priorities Across …

WEBForward Looking Statements The contents of this announcement include statements that are, or may be deemed to be, “forward-looking statements.” These forward-looking …

Category:  Health Go Health

argenx to Present at 42nd Annual J.P. Morgan Healthcare …

WEBargenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that …

Category:  Health Go Health

2019 R&D Day May 22, 2019

WEB8:30 AM: argenx Today: Building Leadership in Immunology Tim Van Hauwermeiren, CEO 8:45 AM: ARGX-117: Renaissance in Complement - Therapeutic Potential of C2 Karen …

Category:  Health Go Health

argenx Announces Positive Topline Phase 3 Data from ADAPT …

WEBThe Phase 3 ADAPT-SC trial was a randomized, open-label, parallel-group, multicenter trial evaluating the noninferiority of the pharmacodynamic (PD) effect of SC efgartigimod …

Category:  Health Go Health

Regulations Argenx

WEBWholesale Acquisition Cost*. 73475-3102-3. VYVGART Hytrulo (efgartigimod alfa and hyaluronidase -qvfc) Solution in Vial Injection. 1,008 mg efgartigimod alfa and 11,200 …

Category:  Health Go Health

Top Categories

 › Appendicitis

 › Headaches

 › Gout

 › Women's Health

 › Thyroid

 › Sleep

 › Skin

 › Sexual Health

 › Senior Health

 › Pregnancy

 › Oral Health

 › Neurology

 › Migraine

 › Mental Health

 › Men's Health

 › Menopause

 › Medications

 › Lung Conditions

 › Infectious Disease

 › HIV/AIDS

Popular Searched

 › Health inspector jobs nj

 › United healthcare medicare advantage review

 › Saint augustine for health sciences email

 › Unc health epic log in

 › Health and glow purasaiwakkam

 › Health and glow online shop

 › Health and glow private label

 › Unc health epic training

 › Torrington health and rehab ct

 › Healthpartners central lab mn

Recently Searched

 › Onsite mental health facility

 › Jmir mental health impact factor

 › Touch for health book

 › Modoc county health services alturas

 › Trumpet behavioral health aurora

 › Healthymichiganplan org make account payment

 › San carlos apache tribe health center

 › Resource health houston tx

 › Fort smith behavioral health

 › Countries with universal health care systems